Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
08/2003
08/21/2003US20030157073 Methods for pretreating a subject with apoptotic cells
08/21/2003US20030157026 Photodynamic diagnosis and therapy for insulin-dependent diabetes mellitus
08/21/2003US20030157024 Killing tissues; rupturing microbubbles releasing therapy drug
08/21/2003US20030156972 Irradiation of ispaghula
08/21/2003CA2475768A1 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
08/20/2003EP1335921A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
08/20/2003EP0996469B1 Methods of photoacoustic imaging
08/20/2003CN1437470A COX-2 inhibitors and the preventionof the side effects of radiation therapy
08/19/2003US6609014 Use of PDT to inhibit intimal hyperplasia
08/19/2003US6608050 Especially from a tin porphyrin and a difatty acid ester of a phosphatidyl choline or glycerol; treatment of cancer and other diseases.
08/19/2003US6607722 Methods for inducing the differentiation of monocytes into functional dendritic cells
08/14/2003WO2003066109A1 Nitric oxide in a pathogen inactivation process
08/14/2003WO2003065971A2 Non-myeloablative tolerogenic treatment with tyrphostins
08/14/2003WO2003065888A1 Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications
08/14/2003WO2003045432A8 Treatment of neovascular ophthalmic disease
08/14/2003US20030153965 Electrically conducting nanocomposite materials for biomedical applications
08/14/2003US20030153833 Ultrasound catheter with utility lumen
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153547 Polymeric micellar structure
08/14/2003US20030152577 Antitumor agents; anticancer agents; cyanine dye complex
08/14/2003US20030152558 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
08/14/2003US20030152517 Method and composition for hyperthermally treating cells
08/14/2003CA2474920A1 Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications
08/14/2003CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins
08/13/2003EP1334748A1 Apparatus for photodynamic therapy
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP0840570B1 Apparatus and method for making gas-filled vesicles of optimal size
08/13/2003CN1435261A Thermosetting medical carrier composition with mucosa adsorption
08/12/2003US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent
08/07/2003WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003WO2003064427A1 Tetrapyrrolic macrocycles as photodynamic agents
08/07/2003WO2003064426A1 N, n'-dimethylated n-confused porphyrins
08/07/2003WO2003064424A2 Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
08/07/2003WO2003063915A1 Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
08/07/2003WO2003063902A2 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers
08/07/2003WO2003063901A1 Amino-substituted hypocrellins for use as sonosensitizers
08/07/2003WO2003063900A1 Process for the preparation of a nutrient formulation
08/07/2003WO2003063757A2 Auger effect-based cancer therapy method
08/07/2003WO2002040093A3 Ablation of cells using combined electric field and ultrasound therapy
08/07/2003US20030149012 Vision through photodynamic therapy of the eye
08/07/2003US20030148984 Molecular chemotherapy enhancement of radiotherapy
08/07/2003US20030148926 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
08/07/2003US20030147812 Device and methods for initiating chemical reactions and for the targeted delivery of drugs or other agents
08/07/2003US20030147807 Water soluble paclitaxel derivatives
08/07/2003CA2514518A1 Process for the preparation of a nutrient formulation
08/07/2003CA2474593A1 N, n'-dimethylated n-confused porphyrins
08/07/2003CA2474571A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003CA2474012A1 Auger effect-based cancer therapy method
08/06/2003EP1333274A2 Up-converting reporters for biological and other assays using laser excitation techniques
08/06/2003EP1332764A1 A mucoadhesive thermoresponsive medicament-carrier composition
08/05/2003US6602274 Targeted transcutaneous cancer therapy
08/05/2003CA2089148C Oxidized complex comprising water-soluble carboxypolysaccaride and magnetic iron oxide
08/05/2003CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
08/01/2003CA2418410A1 Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
07/2003
07/31/2003WO2003061696A2 Systems and methods for photodynamic therapy
07/31/2003WO2003061621A2 Dermal application system for aminolevulinic acid-derivatives
07/31/2003WO2003061593A2 Novel targeted compositions for diagnostic and therapeutic use
07/31/2003WO2003015825A3 Conjugate
07/31/2003US20030144570 Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
07/31/2003US20030143217 For therapy of smooth muscle cell hyperplasia; cancer therapy
07/31/2003US20030143161 Medicine, carrier for medicine, method of producing medicine, and method of tumor treatment
07/31/2003US20030143159 Hydrophilic cyanine dyes
07/31/2003US20030141260 Mixing non-toxic endogenous photosensitizer or endogenously-based derivative photosensitizer with fluid; increasing dissolved oxygen content of fluid; exposing to photoradiation activate the photosensitizer
07/31/2003CA2473924A1 Systems and methods for photodynamic therapy
07/31/2003CA2473748A1 Novel targeted compositions for diagnostic and therapeutic use
07/30/2003EP1331479A1 Two-dimensionally quantified image method for distinguishing and quantifying overgrowing tissue or the like
07/30/2003EP1330514A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment
07/29/2003US6600951 Targeting of sebaceous follicles as a Treatment of sebaceous gland disorders
07/29/2003US6599909 Transfection of tumor by an adenovirus encoding a cytosine deaminase gene, administering a dose of 5-fluorocytosine to said individual, treating said individual with a single or multiple fractions of radiation
07/29/2003US6599891 Administering to the subject an amount of a photosensitizer (PS) sufficient to allow said photosensitizer to localize in lesion; irradiating said lesion with light having a wavelength absorbed by said PS
07/29/2003US6599449 X-ray crystallography reagent
07/29/2003US6599234 Heating of magnetic material by hysteresis effects
07/24/2003WO2003059326A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
07/24/2003WO2003059325A1 Magnetic delivery compositions
07/24/2003WO2002049669A3 Electrically responsive promoter system
07/24/2003US20030139466 Autoimmune diseases; administering a photoactive material to blood
07/24/2003US20030139323 Preradiation therapy; side effect reduction
07/23/2003EP1328504A2 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis
07/23/2003EP1328314A1 Tumor treatment
07/23/2003EP1328263A2 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells
07/22/2003US6596481 Dual markers
07/17/2003WO2003057259A2 Indocyanine green (icg) compositions
07/17/2003WO2003057253A1 Oxygen-enhanced pathogen inactivation
07/17/2003WO2002011713A3 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
07/17/2003US20030134860 Piperazine-containing macrocyclic compounds
07/17/2003US20030134824 The invention provides beta -cyclodextrin dimers and phthalocyanines which can be used in photodynamic therapy of cancer.
07/17/2003US20030134813 Method for introducing molecules in cells by disrupting endosomal and lysosomal membranes using photodynamic treatment, without killing the majority of the cells by the photodynamic treatment. More particularly, this invention
07/17/2003US20030134793 Water soluble compositions of paclitaxel and docetaxel formed by conjugating the paclitaxel or docetaxel to a water soluble polymer such as poly-glutamic acid, poly- aspartic acid or -lysine. Methods of using the compositions for treatment of
07/17/2003US20030133940 Medicaments for chemotherapeutic treatment of disease
07/17/2003US20030133932 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
07/17/2003US20030133914 Method for suppressing immune system response to transplanted tissue or cells
07/17/2003US20030132165 Neutralize or prevent the growth of and/or remove a certain number of undifferentiated animal cells, tumor cells, algae, bacteria or viruses from a sample with high-frequency ultrasound emission
07/16/2003CN1430515A Divided dose therapies with vascular damaging activity
07/10/2003WO2003055887A1 Conjugated porphyrin, chlorin or bacteriochlorin chromophore
07/10/2003WO2003055520A1 Delivery of neutron capture elements for neutron capture therapy
07/10/2003WO2002003850A3 Photoselective marking of biological targets
07/10/2003US20030130341 Taxoids formed by conjugating paclitaxel/docetaxel to polyglutamic acid, polyaspartic acid, or polylysine; antitumor agents; treatment of rheumatoid arthritis and autoimmune diseases
07/10/2003US20030130196 Administering angiotensin; antitumor agents; side effect reduction
07/10/2003US20030130190 Drug delivery; bioavailability; side effect reduction
07/10/2003US20030130178 Water soluble paclitaxel dervatives
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 95